Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4261]

New clinical trials unit opens at The Christie

New clinical trials unit opens at The Christie

Plans for speedier cancer diagnosis in the UK

Plans for speedier cancer diagnosis in the UK

Cancer is UK's biggest fear but 34 per cent put it down to fate

Cancer is UK's biggest fear but 34 per cent put it down to fate

Study confirms long-lasting benefit of radiotherapy in DCIS

Study confirms long-lasting benefit of radiotherapy in DCIS

SABCS 2010: Denosumab delayed time to first skeletal-related side effect for bone metastases from breast cancer

SABCS 2010: Denosumab delayed time to first skeletal-related side effect for bone metastases from breast cancer

SABCS 2010: Circulating tumour cells predicted recurrence and mortality in patients with early-stage breast cancer

SABCS 2010: Circulating tumour cells predicted recurrence and mortality in patients with early-stage breast cancer

SABCS 2010: High circulating tumour cell levels indicate poor outcome in metastatic breast cancer

SABCS 2010: High circulating tumour cell levels indicate poor outcome in metastatic breast cancer

SABCS 2010: Circulating tumour cells predict outcome from blood stem cell therapy for metastatic breast cancer

SABCS 2010: Circulating tumour cells predict outcome from blood stem cell therapy for metastatic breast cancer

SABCS 2010: Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer

SABCS 2010: Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer

SABCS 2010: Combination therapy reduced HER2-positive breast cancers

SABCS 2010: Combination therapy reduced HER2-positive breast cancers

More from ecancer